By stratifying the somatic mutations by clinical tumor subgroup, ductal BCs displayed mostly TP53 and PIK3CA mutations, lobular tumors displayed CDH1 and PIK3CA mutations, and approximately 90% of medullary BCs harbored TP53 mutations [93]. This evidence concerns the gene TP53 and neoplasm.